Guidelines, minimal requirements and standard of cancer care around the Mediterranean Area: Report from the Collaborative AROME (Association of Radiotherapy and Oncology of the Mediterranean Area) working parties

Critical Reviews in Oncology/Hematology

Volumn 78, Issue 1, 2011, Pages 1-16

  Arome, ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

Cancer care; Guidelines; Mediterranean Area; Recommendations

Indexed keywords

OXALIPLATIN; TAMOXIFEN;

BLADDER CANCER; BREAST CANCER; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; CYSTOSCOPY; GYNECOLOGICAL EXAMINATION; HEAD AND NECK CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG CANCER; MEDIASTINOSCOPY; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; REVIEW; SENTINEL LYMPH NODE BIOPSY; SOUTHERN EUROPE; UTERINE CERVIX CARCINOMA;

HUMANS; MEDICAL ONCOLOGY; MEDITERRANEAN REGION; NEOPLASMS; RADIATION ONCOLOGY; STANDARD OF CARE;

EID: 79952360279     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2010.03.007     Document Type: Review

References (64)

1. Committee to Advise the Public Health Service on Clinical Practice Guidelines Institute of Medicine Clinical practice guidelines: directions for a new program 1990, National Academy Press, Washington, DC. M.J. Field, K.N. Lohr (Eds.).
2. Anderson B.O., Jakesz R. Breast cancer issues in developing countries: an overview of the breast health global initiative. World J Surg 2008, 32:2578-2585.
3. Pentheroudakis G., Stahel R., Hansen H., Pavlidis N. Heterogeneity in cancer guidelines: should we eradicate or tolerate?. Ann Oncol 2008, 19:2067-2078.
4. Woolf S.H., Grol R., Hutchinson A., Eccles M., Grimshaw J. Clinical guidelines: potential benefits, limitations, and harm of clinical guidelines. BMJ 1999, 318:527-530.
5. Fervers B., Philip T., Browman G.P. Critical appraisal of the MCR of the European Society for Medical Oncology: challenges for a European framework for the development of clinical practice guidelines. Ann Oncol 2002, 13:1507-1510.
6. Ward E., Halpern M., Schrag N., Schrag N.M., Bian J., Chen A.Y. Association of insurance with cancer care utilisation and outcomes. CA Cancer J Clin 2008, 58:9-31.
7. Norheim O.F. High-cost therapy. Ethical principles of allocation of scarce resources. Tidsskr Nor Laegeforen 1992, 112:3115-3118.
8. World Health Organisation Science and technology for health promotion in developing countries. WHO Chron 1979, 33:399-406.
9. Brenner H., Hoffmeister M., Haug U. Should colorectal cancer screening start at the same age in European countries? Contributions from descriptive epidemiology. Br J Cancer 2008, 99:532-535.
10. Cheung W.Y., Pond G.R., Rother M., et al. Adherence to surveillance guidelines after curative resection for stage II/III colorectal cancer. Clin Colorectal Cancer 2008, 7:191-196.
11. Fissah A. Evidence based medicine. The facts in the South countries. Rev Mal Respir 2006, 23:10S13-110S.
12. Report on the third intercountry meeting on cancer control and prevention, Cairo, Egypt; 2001. WHO-EM/NCD/029/E/l/02/02/07.
13. Adib SM. Lebanon National Cancer Registry. http://www.emro.who.int/ncd/publications/NCR-LEB-02.
14. Al-Kayed S. Jordan National Cancer Registry. http://www.mecc.cancer.gov/publications/epidem.htlm.
15. Hamouda D., Bouhadef A. Registres des tumeurs d'Alger. Publications annιe 2003, vol. 4. Institut national de sante Publique, chemin El Bakr, Alger.
16. Parkin D.M., Ferlay J., Hamdi Cherif M Cancer in Africa: epidemiology and prevention. IARC Scientific publications no. 153 2003, IARC Press Lyon, p. 414.
17. Chaouki N., El Gueddari B. Epidemiological descriptive approach of cancer in Morocco through the activity of the national institute of oncology 1986-1987. Bull Cancer 1991, 78:603-609.
18. Macbeth F.R., Abratt R.P., Cho K.H., Stephens R.J., Jeremic B. Lung cancer management in limited resource settings: guidelines for appropriate good care. Radiother Oncol 2007, 82:123-131. International Atomic Energy Agency.
19. Anderson B.O., Shyyan R., Eniu A., et al. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J 2006, 12:S3-S15.
20. Eniu A., Carlson R.W., Aziz Z., et al. Global summit treatment and allocation of resources panel. Breast cancer in limited-resource countries: treatment and allocation of resources. Breast J 2006, 12:S38-S53.
21. http://www.nccn.org/professionals/physician_gls/recently_updated.asp.
22. Love R. Clinical research in the developing world. ASCO breast cancer symposium 2008 educational book 2008, 68-69.
23. Donato F., Gelatti U., Limina R.M., Fattovich G. Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence. Oncogene 2006, 25:3756-3770.
24. La Vecchia C., Bosetti C. Diet and cancer risk in Mediterranean countries: open issues. Public Health Nutr 2006, 9:1077-1082.
25. Menendez J.A., Lupu R. Mediterranean dietary traditions for the molecular treatment of human cancer: anti-oncogenic actions of the main olive oil's monounsaturated fatty acid oleic acid (18:1n-9). Curr Pharm Biotechnol 2006, 7:495-502.
26. Rubba P., Mancini F.P., Gentile M., Mancini M. The Mediterranean diet in Italy: an update. World Rev Nutr Diet 2007, 97:85-113.
27. Bogani P., Visioli F. Antioxidants in the Mediterranean diets: an update. World Rev Nutr Diet 2007, 97:162-179.
28. Omar S., Alieldin N.H., Khatib O.M. Cancer magnitude, challenges and control in the Eastern Mediterranean region. East Mediterr Health J 2007, 13:1486-1496.
29. Zeghichi-Hamri S., Kallithraka S. Mediterranean diet in the Maghreb: an update. World Rev Nutr Diet 2007, 97:139-161.
30. Coleman M.P., Quaresma M., Berrino F., et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008, 9:730-756.
31. McCarthy M., Datta P., Khachatryan A., Coleman M.P., Rachet B. Would compliance with cancer care standards improve survival for breast, colorectal and lung cancers?. J Epidemiol Community Health 2008, 62:650-654.
32. Smith T.J., Hilnner B.E. Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways. J Clin Oncol 2001, 19:2886-2897.
33. Ray-Coquard I., Philip T., de Laroche G., et al. A controlled "before-after" study: impact of a clinical guidelines programme and regional cancer network organisation on medical practice. Br J Cancer 2002, 86:313-321.
34. Shiffman R.N., Shekelle P., Overhage M., Slutsky J., Grimshaw J., Deshpande A.M. Standardising reporting of clinical practice guidelines: a proposal from the conference on guideline standardisation. Ann Intern Med 2003, 139:493-498.
35. AGREE Collaboration Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care 2003, 12:18-23.
36. ADAPTE Manual for guideline adaptation 2007, ADAPTE Group. http://www.adapte.org/.
37. GRADE Working Group Grading quality of evidence and strength of recommendations. BMJ 2004, 328:1490-1497.
38. SIGN 50 A guideline developer's handbook 2004, Scottish Intercollegiate Guidelines Network, Edinburgh. http://www.sign.ac.uk/guidelines/fulltext/50/index.html.
39. National Institute for Health Clinical Excellence The guidelines manual 2007, National Institute for Health and Clinical Excellence, London. http://www.nice.org.uk/.
40. Pavlidis N. Towards a convenient way to practice medical oncology. Ann Oncol 2007, 18(S2). p. ii3-ii4.
41. Fervers B., Philip T., Haugh M., Cluzeau F., Browman G. Clinical practice guidelines in Europe: time for European co-operation for cancer guidelines. Lancet Oncol 2003, 4:139-140.
42. Eisinger F., Geller G., Burke W., Holtzman N.A. Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer. Lancet 1999, 353:191-200.
43. Desch C.E., McNiff K.K., Schneider E.C., et al. American society of clinical oncology/national comprehensive cancer network quality measures. J Clin Oncol 2008, 26:3631-3637.
44. Yip C.H., Anderson B.O. The breast health global initiative: clinical practice guidelines for management of breast cancer in low- and middle-income countries. Expert Rev Anticancer Ther 2007, 7:1095-1104.
45. Anderson B.O., Carlson R.W. Guidelines for improving breast health care in limited resource countries: the Breast Health Global Initiative. J Natl Compr Cancer Netw 2007, 5:349-356.
46. Bese N.S., Kiel K., El-Gueddari Bel-K., et al. Radiotherapy for breast cancer in countries with limited resources: program implementation and evidence-based recommendations. Breast J 2006, 12:S96-S102.
47. Anderson B.O., Yip C.H., Ramsey S.D., et al. Breast cancer in limited-resource countries: health care systems and public policy. Breast J 2006, 12:S54-S69.
48. Shyyan R., Masood S., Badwe R.A., et al. Breast cancer in limited-resource countries: diagnosis and pathology. Breast J 2006, 12:S27-S37.
49. Anderson B.O. Breast healthcare and cancer control in limited-resource countries: a framework for change. Nat Clin Pract Oncol 2006, 3:4-5.
50. V. Gupta, Clinical care in the developing world, p. 61-62.
51. E. Cazap, Breast cancer in Latin America, p. 63-65.
52. B.O. Anderson, The breast health global initiative: guideline implementation in low- and middle-income countries, p. 66-67.
53. United Nations Human development report 2004 2004, United Nations Development Programme, New York.
54. Marmot M. Social determinants of health inequalities. Lancet 2005, 365:1099-1104.
55. Khabir A. WHO's activities in the Eastern Mediterranean Region. Lancet Oncol 2003, 4:6.
56. da Costa e Silva V.L. Health consequences of the tobacco epidemic in West African French-speaking countries and current tobacco control. Promot Educ 2005, (4). p. 7-12, 54.
57. Donkin A., Goldblatt P., Lynch K. Inequalities in life expectancy by social class 1972-1999. Health Stat Q 2002, 15:5-15.
58. Mackenbach J.P., Bos V., Andersen O., et al. Widening socioeconomic inequalities in mortality in six Western European countries. Int J Epidemiol 2003, 32:830-837.
59. Crimmins E.M., Saito Y. Trends in healthy life expectancy in the United States, 1970-1990: gender, racial, and educational differences. Soc Sci Med 2001, 52:1629-1641.
60. http://www.who.int/chp/steps/en/.
61. http://cancer.iaea.org/.
62. http://www.searo.who.int/en/Section1174/Section2469/Section2470.htm.
63. Rawaf S., Dubois E., Khatib O.M., Omar S. Cancer prevention and control in Eastern Mediterranean region. BMJ 2006, 333(October):860-861.
64. Doyal L., Gough I. A theory of human need 1991, Macmillan, London.